Serum selenium and serum lipoprotein subfractions in type 2 diabetic patients / Eman Ahmed Rashed ; Supervised Dina Farouk Elgayar , Dina Mohamed Elabd , Ashraf Ismail Amin
Material type:
- مستوى السيلنيوم فى المصل ومستوى مكونات البروتينات الدهنية فى المصل فى مرضى البول السكرى النوع الثانى [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.M.Sc.2012.Em.S (Browse shelf(Opens below)) | Not for loan | 01010110060334000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.M.Sc.2012.Em.S (Browse shelf(Opens below)) | 60334.CD | Not for loan | 01020110060334000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
Cai01.11.07.M.Sc.2012.Em.M Monocytes expression of soluble VEGF receptor-1 (sFLT-1) in patients with sickle cell nephropathy / | Cai01.11.07.M.Sc.2012.Em.M Monocytes expression of soluble VEGF receptor-1 (sFLT-1) in patients with sickle cell nephropathy / | Cai01.11.07.M.Sc.2012.Em.S Serum selenium and serum lipoprotein subfractions in type 2 diabetic patients / | Cai01.11.07.M.Sc.2012.Em.S Serum selenium and serum lipoprotein subfractions in type 2 diabetic patients / | Cai01.11.07.M.Sc.2012.En.E Expression of phosphorylated stats in acute myeloid leukemia / | Cai01.11.07.M.Sc.2012.En.E Expression of phosphorylated stats in acute myeloid leukemia / | Cai01.11.07.M.Sc.2012.Fa.D Distribution of ABO and Rh-D blood groups in healthy Egyptian population / |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology
Type 2 Diabetic Mellitus (DM) is rapidly rising as a global health care problem that is threatening to reach pandemic levels by 2030 . Type 2 MD is the leading cause of blindness , non traumatic lower limb amputation and chronic kidney disease in the United States . It is a major cause of cardiovascular disease leading to early death . The increasing incidence of type 2 MD is largely attributable to changes in life style (diet and activity level) and obesity
Issued also as CD
There are no comments on this title.